In breast cancer, S-nitrosylation of Ras induces MAPK-dependent phosphorylation and activates ETS-1 (Erythroblastosis virus transcription factor-1), a critical mediator of nitric oxide, resulting in an aggressive breast cancer phenotype [81]. Here, ETS1 is linked to breast cancer.